HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial. [electronic resource]
Producer: 20210428Description: 944-954 p. digitalISSN:- 1460-2105
- Adenocarcinoma -- diagnosis
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bayes Theorem
- Capecitabine -- therapeutic use
- Cohort Studies
- Colorectal Neoplasms -- diagnosis
- Female
- Fluorescence Resonance Energy Transfer
- Humans
- Latent Class Analysis
- Male
- Microscopy -- methods
- Middle Aged
- Oxaloacetates -- therapeutic use
- Prognosis
- Protein Multimerization
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Receptor, ErbB-2 -- analysis
- Receptor, ErbB-3 -- analysis
- Tissue Array Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.